GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

eWeLL Co 5038.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,266

+3.94%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥3.39bn

FY2020FY2025

Net income

¥1.09bn

FY2020FY2025

Free cash flow

¥1.23bn

FY2020FY2025

Shareholders' equity

¥3.38bn

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue¥3.39bn¥2.57bn¥2.07bn¥1.60bn¥1.19bn¥790.8m
Gross profit¥2.65bn¥1.94bn¥1.60bn¥1.26bn¥969.5m¥659.6m
Research and development—¥10.7m¥14.2m¥8.6m¥16.0m¥16.0m
Operating income¥1.54bn¥1.14bn¥908.7m¥692.8m¥401.9m¥201.9m
Net income¥1.09bn¥808.3m¥612.9m¥449.6m¥340.3m¥184.9m
Diluted earnings per share71.1052.9140.0432.3022.4412.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets¥4.28bn¥3.10bn¥2.41bn¥1.65bn¥1.06bn¥611.0m
Cash and short-term investments¥2.86bn¥1.97bn¥1.41bn¥1.08bn¥617.1m¥326.7m
Total liabilities¥908.4m¥687.0m¥719.8m¥545.0m¥557.1m¥447.1m
Debt——¥91.5m¥96.1m¥180.6m¥225.2m
Shareholders' equity¥3.38bn¥2.41bn¥1.69bn¥1.11bn¥504.2m¥163.9m
Shares outstanding15m15m15m14m15m15m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations¥1.27bn¥856.8m¥626.9m¥543.4m¥408.6m¥195.9m
Capital spending−¥42.2m−¥17.7m−¥186.2m−¥16.0m−¥61.6m−¥16.0m
Free cash flow¥1.23bn¥839.1m¥440.7m¥527.3m¥347.1m¥179.8m
Dividends paid−¥181.1m−¥149.2m−¥104.4m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥1.04bn¥953.9m¥918.6m¥870.7m¥849.1m¥754.1m¥711.6m¥654.5m
Gross profit¥800.2m¥715.3m¥700.3m¥683.9m¥666.4m¥603.9m¥563.1m¥512.1m
Operating income¥512.2m¥434.4m¥341.5m¥407.5m¥411.6m¥376.8m¥312.5m¥295.1m
Net income¥358.8m¥305.1m¥255.8m¥284.4m¥286.2m¥261.9m¥229.0m¥213.4m
Diluted earnings per share23.6620.1216.7118.5818.7017.1114.9913.97
Total assets¥4.35bn¥3.72bn¥4.28bn¥3.70bn¥3.52bn¥2.98bn¥3.10bn¥2.61bn
Cash and short-term investments¥2.81bn¥2.29bn¥2.86bn¥2.41bn¥2.22bn¥1.86bn¥1.97bn¥1.56bn
Shareholders' equity¥3.54bn¥3.15bn¥3.38bn¥3.11bn¥2.82bn¥2.49bn¥2.41bn¥2.17bn

Financial ratios

Data as of 21 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin78.3%75.6%77.4%78.5%81.3%83.4%
Operating margin45.3%44.3%43.9%43.2%33.7%25.5%
Net margin32.1%31.4%29.6%28.0%28.5%23.4%
Return on equity32.2%33.6%36.3%40.7%67.5%112.8%
Return on assets25.4%26.1%25.4%27.2%32.1%30.3%
Free cash flow yield4.1%2.7%2.5%1.9%——
Revenue growth31.9%24.3%29.1%34.4%50.8%—
Earnings growth34.6%31.9%36.3%32.1%84.1%—
Current ratio4.46x4.52x3.15x3.11x2.28x1.84x
Debt to equity——0.05x0.09x0.36x1.37x
Equity ratio78.8%77.8%70.1%67.0%47.5%26.8%
Interest coverage4548.73x488.04x274.46x120.05x147.54x126.51x
R&D as a share of sales—0.4%0.7%0.5%1.3%2.0%
Buybacks as a share of market value-0.2%0.2%-10.0%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue28.4%33.8%—
Operating income30.4%50.1%—
Net income34.3%42.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.1%77.4%78.2%—
Operating margin44.9%44.4%42.0%—
Net margin31.8%30.7%30.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings36.937.150.256.3
Price to sales11.811.714.915.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 29 Dec 2025.

FY2025FY2024FY2023
Paid in the year28.0010.007.50
  • 2-for-1 split · 28 Dec 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.